JAK-STAT signaling activated by Abl oncogenes

被引:115
作者
Danial, NN [1 ]
Rothman, P [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Microbiol, Integrated Program Mol Cellular & Biophys Studies, New York, NY 10032 USA
关键词
JAK; STAT; v-Abl; BCR-Abl;
D O I
10.1038/sj.onc.1203484
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Abl oncoproteins v-Abl and BCR-Abl can activate member of the signal transducers and activators of transcription (STAT) family of signaling proteins. The mechanisms by which these oncoproteins activate STATs appear to differ, In cells transformed by v-Abl, Janus kinase (JAK) tyrosine kinases are constitutively activated. Tn these cells, the v-Abl oncoprotein and the JAK kinases physically associate. Mapping of the JAK interaction domain in v-Abl demonstrates that amino acids within the carboxyl terminal region of v-Abl bind JAKs through a direct interaction. A mutant of v-Abl lacking this region does not bind or activate JAK 1 in vivo, fails to activate STAT proteins, does not induce cellular proliferation, and is less efficient in cellular transformation. Kinase inactive mutants of JAK 1 inhibit the ability of v-Abl to activate STATs, to induce cytokine-independent proliferation, and to transform bone marrow cells. Interestingly, these effects correlate with defects in the activation of several pathways by v-AbI including Akt, PI3-kinase, STATs, and Ras, These data suggest that Jak kinases may play an important role in v-Abl induced transformation.
引用
收藏
页码:2523 / 2531
页数:9
相关论文
共 80 条
[51]   Association of CrkL with STAT5 in hematopoietic cells stimulated by granulocyte-macrophage colony-stimulating factor or erythropoietin [J].
Ota, J ;
Kimura, F ;
Sato, K ;
Wakimoto, N ;
Nakamura, Y ;
Nagata, N ;
Suzu, S ;
Yamada, M ;
Shimamura, S ;
Motoyoshi, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (03) :779-786
[52]   INTERLEUKIN-7 RETROVIRUSES TRANSFORM PRE-B CELLS BY AN AUTOCRINE MECHANISM NOT EVIDENT IN ABELSON MURINE LEUKEMIA-VIRUS TRANSFORMANTS [J].
OVERELL, RW ;
CLARK, L ;
LYNCH, D ;
JERZY, R ;
SCHMIERER, A ;
WEISSER, KE ;
NAMEN, AE ;
GOODWIN, RG .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) :1590-1597
[53]  
Ozaki K, 1998, BLOOD, V92, P4652
[54]  
PAPADOPOULOS P, 1995, CANCER RES, V55, P34
[55]   Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia [J].
Peeters, P ;
Raynaud, SD ;
Cools, J ;
Wlodarska, I ;
Grosgeorge, J ;
Philip, P ;
Monpoux, F ;
VanRompaey, L ;
Baens, M ;
VandenBerghe, H ;
Marynen, P .
BLOOD, 1997, 90 (07) :2535-2540
[56]  
PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7
[57]   EARLY LYMPHOCYTE EXPANSION IS SEVERELY IMPAIRED IN INTERLEUKIN-7 RECEPTOR-DEFICIENT MICE [J].
PESCHON, JJ ;
MORRISSEY, PJ ;
GRABSTEIN, KH ;
RAMSDELL, FJ ;
MARASKOVSKY, E ;
GLINIAK, BC ;
PARK, LS ;
ZIEGLER, SF ;
WILLIAMS, DE ;
WARE, CB ;
MEYER, JD ;
DAVISON, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1955-1960
[58]   SEQUENCES OF THE A-MULV PROTEIN NEEDED FOR FIBROBLAST AND LYMPHOID-CELL TRANSFORMATION [J].
PRYWES, R ;
FOULKES, JG ;
ROSENBERG, N ;
BALTIMORE, D .
CELL, 1983, 34 (02) :569-579
[59]   THE BCR-ABL LEUKEMIA ONCOGENE ACTIVATES JUN KINASE AND REQUIRES JUN FOR TRANSFORMATION [J].
RAITANO, AB ;
HALPERN, JR ;
HAMBUCH, TM ;
SAWYERS, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11746-11750
[60]  
ROSENBERG N, 1994, SEMIN CANCER BIOL, V5, P95